Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 428 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Acute Kidney Insufficiency Clear all

Conditions: Acute Kidney Injury
Interventions: BCT197 Part A, Placebo, BCT197 Part B; Drug
Lead sponsor: Mereo BioPharma; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 6
States / cities: Orange, California • Saginaw, Michigan • Lincoln, Nebraska + 3 more

Conditions: Congenital Heart Disease, Cardiopulmonary Bypass
Interventions: Acetaminophen; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 1 Day to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Acute Kidney Injury, Premature Infant
Interventions: Near Infrared Spectroscopy; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 1 Minute to 7 Days
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Delirium, Ischemic Stroke, Acute Kidney Injury, Heart Valve Disease, Coronary Artery Disease
Interventions: CardioGard Embolic Protection Cannula, Standard Aortic Cannula; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 60 Years and older
Enrollment: 842 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 20
States / cities: North Little Rock, Arkansas • Los Angeles, California • Atlanta, Georgia + 16 more

Conditions: Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Interventions: Treosulfan, Fludarabine; Drug
Lead sponsor: medac GmbH; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Chicago, Illinois • Columbus, Ohio • Richmond, Virginia

Conditions: Respiratory Failure, Respiratory Arrest, Respiratory Distress Syndrome, Acute Respiratory Failure, Acute Respiratory Failure With Hypoxia, Acute Respiratory Failure With Hypercapnia, Acute Respiratory Failure Post Surgical, Acute Respiratory Failure Postprocedural, Acute Respiratory Failure Following Trauma and Surgery, Acute Respiratory Failure Requiring Reintubation, Acute Respiratory Failure Post Traumatic, Acute Respiratory Decompensation, Shock, Shock, Septic, Shock, Cardiogenic, Acute Cardiac Failure, Multi Organ Failure, Acute Kidney Failure
Interventions: Observational retrospective cohort to describe data validity; and Data reliability; and Completeness of the data; Other
Lead sponsor: Efficacy Care R&D Ltd; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 50,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: End Stage Renal Disease, Acute Kidney Injury, Chronic Kidney Disease Stage 5
Interventions: Hemodialysis; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Cardiopulmonary Bypass, Cardiac Surgery, Kidney Injury, Acute
Interventions: Blood and urine collection; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 88 Years
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Kidney Disease, Kidney Failure, Kidney Failure, Chronic, Healthy Volunteers, Renal Tubular Toxicity
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 3 Years and older
Enrollment: 226 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Acute Kidney Injury, Ischemia Reperfusion Injury
Interventions: Valproic Acid Solution, Isotonic saline solution; Drug
Lead sponsor: Westat; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Baltimore, Maryland • Seattle, Washington

Conditions: Chronic Kidney Diseases, Acute Kidney Injury
Interventions: Creatinine, eGFR; Diagnostic Test
Lead sponsor: Nova Biomedical; Industry
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Medley, Florida • Miami Gardens, Florida • Miami Lakes, Florida

Conditions: Acute Kidney Injury, Adverse Drug Reaction, Acute Kidney Failure, Kidney Failure, Kidney Disease
Interventions: Not listed
Lead sponsor: Ravindra Mehta; Other
Eligibility: 2 Years and older
Enrollment: 634 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 8
States / cities: Birmingham, Alabama • San Diego, California • Aurora, Colorado + 4 more

Conditions: Delayed Graft Function
Interventions: ANG-3777, Placebo; Drug · Other
Lead sponsor: Angion Biomedica Corp; Industry
Eligibility: 18 Years and older
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 30
States / cities: Phoenix, Arizona • Los Angeles, California • Sacramento, California + 24 more

Conditions: Acute Kidney Injury
Interventions: Pediatric Quality of Life (Peds QL) Survey; Other
Lead sponsor: University of Florida; Other
Eligibility: 2 Years to 36 Years
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Kidney Failure, Acute
Interventions: Pharmacy Dashboard Review and Intervention; Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 540 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Acute Kidney Injury
Interventions: VIDAS® NEPHROCLEAR™ CCL14; Diagnostic Test
Lead sponsor: BioMérieux; Industry
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Acute Kidney Injury, Liver Disease, Chronic Kidney Disease, End Stage Kidney Disease
Interventions: Renal replacement therapy; Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors, Epidemiology, Chronic Kidney Disease(CKD), Hypertension
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 0 Minutes to 2 Weeks
Enrollment: 8,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 53
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Palo Alto, California + 48 more

Conditions: Pediatric Kidney Disease, Acute Kidney Injury
Interventions: HF20™; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Palo Alto, California • Cincinnati, Ohio • Seattle, Washington

Conditions: Acute Kidney Injury
Interventions: electronic alert and clinical decision support system; Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 6 Months to 18 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Chronic Kidney Diseases
Interventions: Visipaque, Placebos; Drug
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 17
States / cities: Birmingham, Alabama • Mesa, Arizona • Little Rock, Arkansas + 14 more

Conditions: Acute Renal Failure (ARF), Acute Kidney Injury (AKI), Fluid Overload in Dialysis Patients
Interventions: Prismaflex HF20; Device
Lead sponsor: Vantive Health LLC; Industry
Eligibility: Not listed
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 5
States / cities: Birmingham, Alabama • Palo Alto, California • Chicago, Illinois + 2 more

Conditions: Acute Renal Failure
Interventions: Standard dose of dialysis, High dose of dialysis; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Acute Kidney Injury, Exercise-associated Hyponatremia, Perceived Exertion
Interventions: Ibuprofen, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Stanford, California

Search by objective public record fields.

Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery

Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass

NIRS Monitoring to Detect AKI in Preterm Infants

CTSN Embolic Protection Trial

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Postoperative Respiratory Abnormalities

Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients

Cardiopulmonary Bypass Induced Red Blood Cell Lysis

Search for New Methods to Detect Acute Renal Failure

Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients

Nova Max Creatinine and eGFR Meter System

The Drug Induced Renal Injury Consortium

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Long Term Cognitive Impact of Pediatric Acute Renal Injury

Achieving Medication Safety During Acute Kidney Injury

VIDAS Nephroclear (NCL) CCL14 - Sample Stability

Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant

Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

Registry for HF20 for Pediatric CRRT Under Emergency Use Authorization

AKI Management Using Electronic Alerts

A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease

Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry

High Dose CVVHDF Compared to Standard Dose CVVHDF

Non-steroidal Anti-inflammatory Affect on Kidneys in Endurance Distances